RECENT NEWS

New pre-market regulatory requirements for medical devices and in vitro diagnostic devices entering the GB market have been published by the Medicines and Healthcare products Regulatory Agency (MHRA) on the World Trade Organisation notification portal.

The UK Government has worked with international partners to ensure the safe return of all remaining British nationals on board MV Hondius – the cruise ship which saw an outbreak of hantavirus, with passengers now safely transferred to Arrowe Park Hospital.

LabWise Academy, an Irish-based specialist education platform for medical scientists and laboratory professionals, has launched a new online course focused on IT connectivity in near-patient testing (NPT) - a topic that sits at the intersection of clinical practice, regulatory compliance, and digital health integration.

QIAGEN has announced plans to advance its QuantiFERON latent tuberculosis (TB) test with a new fully automated sample-to-insight workflow and a separate AI-enabled risk stratification tool for TB progression.

A new study suggests a simple finger prick blood test combined with online brain testing, all done at home, could help identify people at risk of developing dementia.

Roche has announced that it has entered into a definitive merger agreement to acquire PathAI, a US-based company in digital pathology and AI-powered technology for pathology laboratories and the biopharma industry.

Mast Group was recently recognised for its contribution to bowel cancer screening, receiving the Primary / Social Care Partnership Award at the Medilink North of England Healthcare Business Awards 2026.

The National Institute for Health and Care Excellence (NICE) has announced the appointment of Dr Adrian Hayter as its new Chief Medical Officer, bolstering the institute’s clinical leadership, following the appointment of CEO Professor Jonathan Benger last year.

Epigenetics company VolitionRx has announced a technical milestone with the successful detection of nucleosomes in capillary blood from critically ill sepsis patients using its lateral flow prototype.

The Royal College of Pathologists (RCPath) recently welcomed 100 stakeholders from across diagnostics and pharmaceutical industries, government, trade associations and its membership for a one-day Industry Leaders’ Forum to support delivery of its corporate engagement strategy.

Tens of thousands of patients could benefit from a ‘rapid’ new immunotherapy jab on the NHS for over a dozen different cancers, which can be given in just 60 seconds.

The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the appointment of Jason Bonander as its new Chief Digital and Technology Officer (CDTO).

Lab Thread, a UK-based life science software company, has announced the worldwide commercial release of its Unified Lab Software Platform, which connects scientific teams, data and workflows within a single, fully integrated digital laboratory management system.

Join our free webinar on Friday 22 May to learn more about how AI is transforming the way laboratories and life sciences organisations approach quality control for their digitally scanned slides.

Analytik Jena is expanding its liquid handling portfolio with a new digital, contact-free dispenser series that enables sample preparation at ultra‑low volumes.

Bio-Rad Laboratories has launched its new PTC Harmony Thermal Cycler line, designed to offer broader access to optimised workflows for PCR applications such as sequencing, cloning, and genotyping.

Diatron, a STRATEC brand specialising in the development, manufacturing, and marketing of haematology and clinical chemistry analysers and related reagents for human and veterinary use, has expanded the capabilities of its Aquila, Aquarius 3, and Abacus 5 analysers with six advanced haematological indices.

Thermo Fisher Scientific has announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion.

Researchers have delivered the UK’s first dose in a new trial using an investigational mRNA vaccine to protect people against potential influenza pandemics such as avian influenza (bird flu).

New independent modelling shows that deploying fast identification and antimicrobial susceptibility testing early in the patient pathway could prevent around 10,000 sepsis cases and 5,200 deaths in the UK every year, as well as saving the NHS approximately £300 million annually.